<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">Metabolic syndrome</z:e> (MetS) is reported to be associated with <z:hpo ids='HP_0001268'>cognitive decline</z:hpo> and <z:hpo ids='HP_0000726'>dementia</z:hpo>, in particular vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>However, the evidence linking MetS to <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> (AD) and amnestic mild <z:hpo ids='HP_0100543'>cognitive impairment</z:hpo> (aMCI), a precursor of AD, is inconsistent and limited </plain></SENT>
<SENT sid="2" pm="."><plain>This study examined the association of MetS and its components with aMCI and how APOE-εe4 and younger age influenced this association </plain></SENT>
<SENT sid="3" pm="."><plain>Participants with aMCI (n = 98) and cognitively <z:mpath ids='MPATH_458'>normal</z:mpath> controls (n = 802) were identified from baseline data in a second wave cohort of older subjects aged 55 and over in the Singapore Longitudinal Ageing Study-2 (SLAS-2) in 2009/2010 </plain></SENT>
<SENT sid="4" pm="."><plain>The associations of MetS and its individual components with aMCI were analyzed using logistic regression controlling for age, gender, education, current smoking, alcohol drink, leisure time activities score, Geriatric <z:hpo ids='HP_0000716'>Depression</z:hpo> Scale score, APOE-ε4, and <z:e sem="disease" ids="C0018799" disease_type="Disease or Syndrome" abbrv="">heart disease</z:e> or <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>The analysis was repeated for associations stratified by age and APOE-ε4 status </plain></SENT>
<SENT sid="6" pm="."><plain>In multivariate analysis, MetS was associated with an elevated risk of aMCI (OR = 1.79; 95% CI 1.15-2.77) </plain></SENT>
<SENT sid="7" pm="."><plain>Among MetS components, central <z:hpo ids='HP_0001513'>obesity</z:hpo> showed a significant association with aMCI (OR = 1.77; 95%CI 1.11-2.82) </plain></SENT>
<SENT sid="8" pm="."><plain>The association between MetS and aMCI remained significant on repeated analysis among subjects free of <z:e sem="disease" ids="C0018799" disease_type="Disease or Syndrome" abbrv="">heart disease</z:e> and <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
<SENT sid="9" pm="."><plain>This association was particularly stronger among participants with APOE-ε4 allele (OR = 3.35; 95% CI, 1.03-10.85) and younger (&lt;65 years) participants with APOE-ε4 (OR = 6.57; 95% CI, 1.03-41.74) </plain></SENT>
<SENT sid="10" pm="."><plain>MetS was found to be associated with aMCI, especially in individuals with APOE-ε4 at younger age in this middle-aged and older cohort </plain></SENT>
</text></document>